Keke Gaitang Pian (可可钙糖片)可可钙糖片

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

其组分为钙是一种在国家药监局注册认定的药品。该药品含有奶粉、氢钙、葡萄糖酸钙-20fb2505等成分。

该药品关联的活性成分包括:奶粉Nai Fen、氢钙Qing Gai、葡萄糖酸钙Putao Tangsuan Gai。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:上海凯合荣图们药业有限公司Chinese legal name: 上海凯合荣图们药业有限公司。

您可以探索含有相同成分的其他药品:奶粉-43e23981成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 可可钙糖片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 奶粉Nai Fen, 氢钙Qing Gai, 葡萄糖酸钙Putao Tangsuan Gai.

Manufacturers recorded for this product: 上海凯合荣图们药业有限公司Chinese legal name: 上海凯合荣图们药业有限公司.

Explore other medicines containing the same ingredient: 奶粉 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 可可钙糖片Recorded Chinese name: 可可钙糖片
  • 剂型Dosage form: 片剂Tablets
  • 规格Specification: 复方Recorded Chinese specification

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 上海凯合荣图们药业有限公司Chinese legal name: 上海凯合荣图们药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H22025009

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H22025009

Manufacturer

Chinese legal name: 上海凯合荣图们药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

Protect from light and keep tightly closed.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H22025009

生产企业

上海凯合荣图们药业有限公司(国产)

适应症

用于防治钙缺乏症。预防、补充和治疗儿童,妊娠期、哺乳期妇女及青春发育期青少年、老年人的钙质不足.

用法用量

口服,一次2~4片,一日3次。

不良反应

尚不明确。

禁忌

1.大量饮用含酒精和咖啡因的饮料以及大量吸烟,均会抑制钙剂的吸收。
2.大量进食富含维生素的食物能抑制钙的吸收,因钙与维生素结合成不易吸收的化合物。
3.本品与苯妥因钠类及四环素类同用,二者吸收减低。
4.维生素D、避孕药、雌激素能增加钙的吸收。
5.含铝的抗酸药与本品同服时,铝的吸收增多。
6.与钙通道阻滞剂(如硝苯地平)同用,血钙可明显升高至正常以上,但盐酸维拉帕米等的作用则降低。
7.本品与噻嗪类利尿药合用时,因增加肾小管对钙的重吸收而易发生高钙血症。
8.本品与含钾药物合

注意事项

1.高钙血症、高尿血症、含钙肾结石或有肾结石病史者禁用。
2.服用洋地黄类药物期间禁用。
3.心肾功能不全者慎用。
4.药品性状发生改变时禁用。
5.如服用过量或发生严重不良反应时应立即就医。
6.儿童必须在成人监护下使用。
7.请将此药品放在儿童不能接触的地方。

贮藏

遮光,密封保存。

规格

复方

证据Evidence

  • 批准文号: 国药准字H22025009
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.